Live Breaking News & Updates on பொருளாதார முதலீடு குழு

Stay updated with breaking news from பொருளாதார முதலீடு குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Adverum Biotechnologies Announces New GMP Gene Therapy Manufacturing Facility


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Adverum Biotechnologies Announces New GMP Gene Therapy Manufacturing Facility
Adverum Biotechnologies, Inc.January 7, 2021 GMT
174,000-square-foot commercial GMP facility in Durham, NC for the manufacturing of ADVM-022, an intravitreal gene therapy in development for wet AMD and DME
Multiple production suites with total capacity of 4000L, with further expansion opportunities
Adverum to invest over $80M to be production-ready by end of 2023 and create more than 200 life sciences jobs; Company to receive state and local incentives of up to $9M  ....

Durham County , North Carolina , United States , Research Triangle Park , Laurent Fischer , Angela Thedinga , Roy Cooper , Adverum Biotechnologies Inc , Media Contact Andrea Cohen Sam Brown Inc , Economic Investment Committee , Carolina Biotechnology Center , Job Development Investment Grant , Carolina Department Of Commerce , Corporate Communications Adverum Biotechnologies Inc , Duke Energy , Economic Development Partnership Of North Carolina , Carolina Community College System , Greater Durham Chamber , Good Manufacturing Practices , Governor Roy , North Carolina Department , Economic Development Partnership , North Carolina General Assembly , North Carolina Community College System , North Carolina Biotechnology Center , Private Securities Litigation Reform Act ,

California gene tech company bringing 200+ jobs at nearly $94k in average pay to Durham


by Jim Shamp, NCBiotech writer January 7, 2021 .
RESEARCH TRIANGLE PARK – California gene therapy innovator Adverum Biotechnologies announced plans today to invest $83 million to establish a manufacturing site in Durham that will employ 202 people at an average salary of $93,762 when fully operational.
It’s the latest in a string of cell- and gene-therapy companies drawn to the Triangle for its trained workforce, academic prowess and attractive business, social and meteorological climate.
The publicly held company, (Nasdaq: ADVM), is a clinical-stage gene therapy company targeting unmet medical needs in serious ocular and rare diseases. Adverum’s lead product candidate, ADVM-022, is a one-time injection into the eye to treat conditions such as wet age-related macular degeneration and diabetic macular edema. ....

United States , North Carolina , University Of North Carolina , Chapel Hill , Redwood City , Laurent Fischer , Angela Thedinga , Economic Investment Committee , Master Of Public Health , Carolina Biotechnology Center , Job Development Investment Grant , Adverum Biotechnologies , Good Manufacturing Practices , Chief Technology Officer Angela Thedinga , Public Health , Novartis Vaccines , Holly Springs , Novartis Gene , Bill Bullock , North Carolina Biotechnology Center , ஒன்றுபட்டது மாநிலங்களில் , வடக்கு கரோலினா , பல்கலைக்கழகம் ஆஃப் வடக்கு கரோலினா , தேவாலயம் மலை , ரெட்வுட் நகரம் , பரிசு பெற்றவர் பிஷ்ஷர் ,